Astera Labs, Inc. (ALAB) and Nova Ltd. (NVMI) are two dynamic players in the semiconductor industry, each innovating within critical segments of chip manufacturing and connectivity. Astera Labs focuses on advanced connectivity solutions for cloud and AI infrastructure, while Nova Ltd. specializes in process control systems essential for semiconductor fabrication. Given their market overlap and cutting-edge technologies, this article will help you decide which company presents a more compelling investment opportunity in 2026.
Table of contents
Companies Overview
I will begin the comparison between Astera Labs and Nova Ltd. by providing an overview of these two companies and their main differences.
Astera Labs Overview
Astera Labs, Inc. designs and sells semiconductor-based connectivity solutions focused on cloud and AI infrastructure. Its Intelligent Connectivity Platform includes data, network, and memory connectivity products built on a software-defined architecture. Founded in 2017 and based in Santa Clara, California, Astera Labs positions itself as a key enabler for high-performance cloud and AI infrastructure at scale.
Nova Ltd. Overview
Nova Ltd. develops process control systems for semiconductor manufacturing, offering metrology platforms for various process steps such as lithography and etch. Founded in 1993 and headquartered in Rehovot, Israel, Nova serves integrated circuit manufacturers globally, including logic, foundries, and memory sectors. It emphasizes precision process control across multiple semiconductor production stages.
Key similarities and differences
Both Astera Labs and Nova operate in the semiconductor industry with a focus on enabling semiconductor manufacturing and infrastructure. Astera Labs concentrates on connectivity solutions for cloud and AI applications, while Nova specializes in metrology and process control systems for semiconductor fabrication. The companies differ in their product focus and geographic base, with Astera Labs rooted in the US and Nova in Israel, serving global manufacturing clients.
Income Statement Comparison
Below is a side-by-side comparison of key income statement metrics for Astera Labs, Inc. Common Stock (ALAB) and Nova Ltd. (NVMI) for the fiscal year 2024.
| Metric | Astera Labs, Inc. Common Stock (ALAB) | Nova Ltd. (NVMI) |
|---|---|---|
| Market Cap | 29.5B USD | 12.9B USD |
| Revenue | 396.3M USD | 672.4M USD |
| EBITDA | -113.0M USD | 204.9M USD |
| EBIT | -116.1M USD | 187.5M USD |
| Net Income | -83.4M USD | 183.8M USD |
| EPS | -0.64 USD | 6.31 USD |
| Fiscal Year | 2024 | 2024 |
Income Statement Interpretations
Astera Labs, Inc. Common Stock
Astera Labs showed strong revenue growth from 79.9M in 2022 to 396.3M in 2024, a 396% increase overall. However, net income remained negative, though losses narrowed from -58.3M in 2022 to -83.4M in 2024. Gross margins stayed favorable near 76.4%, but EBIT and net margins remained negative in 2024, reflecting ongoing operating challenges despite revenue expansion.
Nova Ltd.
Nova Ltd. demonstrated consistent revenue growth from 269.4M in 2020 to 672.4M in 2024, a 150% increase overall. Net income rose significantly, reaching 184.9M in 2024 from 47.9M in 2020. Margins remained favorable, with a gross margin of 57.6% and a strong EBIT margin of 27.9% in 2024. The firm reported solid profit growth and margin stability in the most recent year.
Which one has the stronger fundamentals?
Nova Ltd. presents stronger fundamentals with favorable margins and consistent net income growth, including a 27.3% net margin in 2024. Astera Labs’ impressive revenue growth contrasts with persistent net losses and negative operating margins. Nova’s overall income statement evaluation is favorable, while Astera Labs holds a neutral stance, reflecting more balanced but challenging profitability metrics.
Financial Ratios Comparison
The table below presents a side-by-side comparison of key financial ratios for Astera Labs, Inc. Common Stock (ALAB) and Nova Ltd. (NVMI) based on their most recent fiscal year data from 2024.
| Ratios | Astera Labs, Inc. (ALAB) | Nova Ltd. (NVMI) |
|---|---|---|
| ROE | -8.65% | 19.81% |
| ROIC | -11.97% | 13.39% |
| P/E | -208.41 | 31.20 |
| P/B | 18.02 | 6.18 |
| Current Ratio | 11.71 | 2.32 |
| Quick Ratio | 11.21 | 1.92 |
| D/E | 0.0013 | 0.2545 |
| Debt-to-Assets | 0.12% | 16.98% |
| Interest Coverage | 0 | 116.20 |
| Asset Turnover | 0.38 | 0.48 |
| Fixed Asset Turnover | 11.12 | 5.06 |
| Payout ratio | 0 | 0 |
| Dividend yield | 0 | 0 |
Interpretation of the Ratios
Astera Labs, Inc. Common Stock
Astera Labs shows several weak financial ratios in 2024, including negative net margin (-21.05%) and return on equity (-8.65%), reflecting profitability challenges. Its very high current ratio (11.71) signals excess liquidity but may indicate inefficient asset use. The company does not pay dividends, likely due to ongoing investments and negative earnings, with no share buyback programs reported.
Nova Ltd.
Nova Ltd. reports strong profitability ratios in 2024, such as a net margin of 27.33% and return on equity of 19.81%, indicating efficient capital use. Its liquidity ratios are solid, with a current ratio of 2.32 and favorable debt metrics. Like Astera Labs, Nova Ltd. pays no dividends, probably prioritizing growth and R&D investments rather than shareholder payouts.
Which one has the best ratios?
Nova Ltd. exhibits a more favorable ratio profile, with approximately 64% favorable metrics, including profitability and liquidity strengths. Astera Labs, by contrast, has about 64% unfavorable ratios, highlighting operational and profitability weaknesses. Nova Ltd.’s ratios suggest a stronger financial position relative to Astera Labs in 2024.
Strategic Positioning
This section compares the strategic positioning of Astera Labs and Nova Ltd., including market position, key segments, and exposure to technological disruption:
Astera Labs, Inc. Common Stock
- Mid-sized player in semiconductors with NASDAQ listing; faces competition in cloud and AI infrastructure connectivity.
- Focuses on semiconductor-based connectivity solutions for cloud and AI infrastructure, driven by Intelligent Connectivity Platform.
- Operates in a fast-evolving technology sector but no explicit data on vulnerability or adaptation to disruption provided.
Nova Ltd.
- Smaller market cap in semiconductors; global presence with exposure to multiple semiconductor manufacturing markets.
- Specializes in metrology platforms for semiconductor process control, targeting logic, foundries, memory, and equipment sectors.
- Serves advanced semiconductor manufacturing; description implies ongoing adaptation to semiconductor process innovations.
Astera Labs vs Nova Ltd. Positioning
Astera Labs concentrates on cloud and AI connectivity with a narrower product focus, while Nova Ltd. has a broader semiconductor process control portfolio and international market reach. Astera Labs is newer and smaller, Nova has longer industry presence and larger workforce.
Which has the best competitive advantage?
Nova Ltd. holds a slightly favorable moat with growing profitability but no strong competitive advantage yet, whereas Astera Labs has a slightly unfavorable moat, destroying value despite improving returns. Both show improving ROIC trends.
Stock Comparison
The stock price chart highlights significant bullish trends for both Astera Labs, Inc. (ALAB) and Nova Ltd. (NVMI) over the past 12 months, with notable price appreciation and differing momentum patterns in recent weeks.
Trend Analysis
Astera Labs, Inc. (ALAB) showed a strong bullish trend over the past year with a 149.21% price increase but exhibited deceleration in momentum. Recent weeks reveal a mild bearish trend with a -6.55% price change. Nova Ltd. (NVMI) delivered a 168.54% price increase over the year with accelerating momentum. Its recent trend is strongly bullish, rising 26.09% since November 2025. Comparing both, NVMI outperformed ALAB in overall market performance, driven by stronger recent bullish momentum and a higher percentage price increase.
Target Prices
The current analyst consensus provides clear target ranges for both Astera Labs, Inc. and Nova Ltd.
| Company | Target High | Target Low | Consensus |
|---|---|---|---|
| Astera Labs, Inc. Common Stock | 225 | 165 | 202.14 |
| Nova Ltd. | 390 | 335 | 362.5 |
Analysts expect Astera Labs to trade above its current price of 174.45 USD, with a consensus target of 202.14 USD. Nova Ltd.’s consensus target of 362.5 USD is notably below its current price of 434.55 USD, suggesting possible overvaluation or increased risk.
Analyst Opinions Comparison
This section compares analysts’ ratings and financial scores for Astera Labs, Inc. Common Stock (ALAB) and Nova Ltd. (NVMI):
Rating Comparison
ALAB Rating
- Rating: B, assessed as very favorable overall.
- Discounted Cash Flow Score: Very unfavorable at 1, indicating potential overvaluation risks.
- ROE Score: Favorable at 4, showing efficient profit generation from equity.
- ROA Score: Very favorable at 5, demonstrating excellent asset utilization.
- Debt To Equity Score: Favorable at 4, reflecting a relatively strong balance sheet.
- Overall Score: Moderate at 3, summarizing a balanced financial standing.
NVMI Rating
- Rating: B-, also categorized as very favorable overall.
- Discounted Cash Flow Score: Moderate at 3, suggesting more balanced valuation.
- ROE Score: Favorable at 4, similarly efficient in profit generation.
- ROA Score: Very favorable at 5, also indicating strong asset utilization.
- Debt To Equity Score: Very unfavorable at 1, indicating higher financial risk.
- Overall Score: Moderate at 3, similarly reflecting balanced financial health.
Which one is the best rated?
Based strictly on the provided data, ALAB holds a slightly better financial risk profile with a favorable debt-to-equity score and a very unfavorable discounted cash flow score. NVMI has a better discounted cash flow score but a significantly weaker debt-to-equity rating, making ALAB comparatively better rated in risk management.
Scores Comparison
Here is a comparison of the Altman Z-Score and Piotroski Score for Astera Labs and Nova Ltd.:
Astera Labs Scores
- Altman Z-Score: 136.88, indicating a safe zone.
- Piotroski Score: 6, classified as average.
Nova Ltd Scores
- Altman Z-Score: 7.76, indicating a safe zone.
- Piotroski Score: 7, classified as strong.
Which company has the best scores?
Based on these scores, Astera Labs has a significantly higher Altman Z-Score indicating stronger financial stability, while Nova Ltd has a better Piotroski Score, reflecting stronger financial health. Each company leads in a different score category.
Grades Comparison
The following presents a detailed comparison of the grades assigned to Astera Labs, Inc. and Nova Ltd. by reputable grading companies:
Astera Labs, Inc. Grades
This table summarizes the latest grades and actions from established grading firms for Astera Labs, Inc.:
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| Northland Capital Markets | Maintain | Outperform | 2025-12-09 |
| Northland Capital Markets | Upgrade | Outperform | 2025-11-17 |
| Stifel | Maintain | Buy | 2025-11-05 |
| Morgan Stanley | Maintain | Overweight | 2025-11-05 |
| Roth Capital | Maintain | Buy | 2025-11-05 |
| Needham | Maintain | Buy | 2025-11-05 |
| JP Morgan | Maintain | Overweight | 2025-11-05 |
| TD Cowen | Maintain | Hold | 2025-11-05 |
| Barclays | Downgrade | Equal Weight | 2025-10-20 |
| Stifel | Maintain | Buy | 2025-10-17 |
Astera Labs shows a predominantly positive trend with multiple buy and outperform ratings maintained or upgraded, except for one recent downgrade.
Nova Ltd. Grades
Below is an overview of the recent grades and recommendations from respected grading companies for Nova Ltd.:
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| B of A Securities | Maintain | Buy | 2026-01-13 |
| Jefferies | Maintain | Buy | 2025-12-15 |
| Evercore ISI Group | Maintain | Outperform | 2025-11-07 |
| Benchmark | Maintain | Buy | 2025-11-07 |
| Cantor Fitzgerald | Maintain | Overweight | 2025-06-24 |
| B of A Securities | Maintain | Buy | 2025-06-24 |
| Benchmark | Maintain | Buy | 2025-05-09 |
| Citigroup | Maintain | Buy | 2025-05-09 |
| B of A Securities | Maintain | Buy | 2025-04-16 |
| Cantor Fitzgerald | Maintain | Overweight | 2025-03-14 |
Grades for Nova Ltd. remain consistently positive, with a strong majority of buy and outperform recommendations maintained over time.
Which company has the best grades?
Both Astera Labs and Nova Ltd. hold predominantly buy and outperform ratings from reputable grading firms, with Astera Labs showing a slight variation due to one downgrade. This consistency may influence investor confidence, reflecting steady analyst support for both stocks.
Strengths and Weaknesses
Below is a comparison of key strengths and weaknesses for Astera Labs, Inc. (ALAB) and Nova Ltd. (NVMI) based on their recent financial and operational data.
| Criterion | Astera Labs, Inc. (ALAB) | Nova Ltd. (NVMI) |
|---|---|---|
| Diversification | Moderate: Revenue mainly from products (393M) with small tech services (3.2M) | Low: Revenue solely from products (538M) |
| Profitability | Weak: Negative net margin (-21.05%) and ROIC (-11.97%), value destroying | Strong: Positive net margin (27.33%) and ROIC (13.39%), value creating |
| Innovation | Improving ROIC trend (+65.5%) but overall value shedding | Growing ROIC trend (+70.1%) with favorable profitability |
| Global presence | Limited data; likely smaller scale | Larger scale with higher revenue and better financials |
| Market Share | Smaller product revenue base (393M) | Larger product revenue base (538M) and growing |
Key takeaway: Nova Ltd. shows stronger profitability and financial health with a favorable investment profile, while Astera Labs is currently value destructive but demonstrating improving operational efficiency. Investors should weigh Nova’s solid fundamentals against Astera’s growth potential but higher risk.
Risk Analysis
Below is a comparative risk table for Astera Labs, Inc. (ALAB) and Nova Ltd. (NVMI) based on their most recent financial and operational data from 2024-2026.
| Metric | Astera Labs, Inc. (ALAB) | Nova Ltd. (NVMI) |
|---|---|---|
| Market Risk | High beta (1.51) implies elevated volatility | Higher beta (1.83) suggests even greater volatility |
| Debt level | Very low debt (D/E = 0.0), minimal financial risk | Moderate debt (D/E = 0.25), manageable but notable leverage |
| Regulatory Risk | Moderate, US semiconductor industry regulatory scrutiny | Higher, operates in multiple countries with varying regulations |
| Operational Risk | Smaller scale (440 employees), potential scaling challenges | Larger scale (1,177 employees), complexity in operations |
| Environmental Risk | Standard semiconductor manufacturing risks | Similar industry exposure, with global footprint adding complexity |
| Geopolitical Risk | US-based, exposed to US-China tech tensions indirectly | Israeli base with operations in Asia and US, higher geopolitical exposure |
In synthesis, NVMI faces higher market volatility and geopolitical risks due to its international presence, while ALAB benefits from a debt-free balance sheet but struggles with operational scaling and profitability. The most impactful risk for ALAB is its unfavorable profitability and operational metrics, while for NVMI, geopolitical and market instability pose significant challenges despite stronger financial health. Investors should weigh these risks carefully against growth prospects in the semiconductor sector.
Which Stock to Choose?
Astera Labs, Inc. (ALAB) shows strong revenue growth of 396% over 2022-2024 but suffers from negative profitability with a net margin of -21.05% and unfavorable ROE and ROIC. Its debt levels are low and rating is very favorable (B), yet financial ratios are mostly unfavorable, indicating value destruction despite improving returns.
Nova Ltd. (NVMI) demonstrates steady income growth of 150% over 2020-2024 with favorable profitability metrics including a net margin of 27.33%, ROE at 19.81%, and ROIC above cost of capital. Although it carries higher debt, its financial ratios and rating (B-) are favorable, reflecting growing profitability and financial strength.
For risk-averse investors prioritizing financial stability and consistent profitability, NVMI’s favorable income and ratio profile might appear more suitable. Conversely, growth-oriented investors focusing on rapid revenue expansion and improving returns could find ALAB’s trajectory more appealing despite current losses and ratio challenges.
Disclaimer: Investment carries a risk of loss of initial capital. The past performance is not a reliable indicator of future results. Be sure to understand risks before making an investment decision.
Go Further
I encourage you to read the complete analyses of Astera Labs, Inc. Common Stock and Nova Ltd. to enhance your investment decisions:
